|
University of California, Los Angeles |
Gene Block |
Major Facilities |
No Title |
$19,854,900 |
|
Beckman Research Institute of City of Hope |
Michael Barish |
Disease Team Planning |
Genetically-modified neural stem cells for treatment of high-grade glioma |
$55,000 |
|
University of California, Merced |
John White |
Major Facilities |
No Title |
$4,359,480 |
|
University of California, San Diego |
Dennis Carson |
Disease Team Planning |
CIRM Planning Grant in Leukemia |
$55,000 |
|
University of California, Santa Barbara |
Glenn Lucas |
Major Facilities |
No Title |
$3,205,800 |
|
The Parkinson's Institute |
Dennis Steindler |
Research Leadership 10 |
Stem Cell Pathologies in Parkinson’s disease as a key to Regenerative Strategies |
$6,718,471 |
|
Stanford University |
Robert Robbins |
Disease Team Planning |
{REDACTED} Cardiovascular Regenerative Team |
$55,000 |
|
University of California, Santa Cruz |
Margaret Delaney |
Major Facilities |
No Title |
$7,191,950 |
|
University of Southern California |
Andrew McMahon |
Research Leadership 10 |
Repair and regeneration of the nephron |
$5,672,206 |
|
University of California, Los Angeles |
Stanley Carmichael |
Disease Team Planning |
Development of a Stem Cell Therapy to Promote Functional Recovery in Stroke |
$44,792 |
|
University of California, San Francisco |
Jeffrey Bluestone |
Disease Team Planning |
A CIRM Disease Team for the Treatment and Cure of Diabetes |
$55,000 |
|
University of California, San Francisco |
A. Washington |
Major Facilities |
No Title |
$34,862,400 |
|
University of Southern California |
David Woodley |
Disease Team Planning |
Clinical Regenerative Wound Healing With Stem Cells |
$42,574 |
|
University of Southern California |
Chrysostomos Nikias |
Major Facilities |
No Title |
$26,972,500 |
|
University of California, San Francisco |
Jeffrey Lotz |
Disease Team Planning |
A CIRM Disease Team for the Repair of Traumatically Injured and Arthritic Cartilage |
$55,000 |
|
University of Southern California |
Mark Humayun |
Disease Team Planning |
Stem cell based treatment strategy for Age-related Macular Degeneration (AMD) |
$50,001 |
|
The Salk Institute for Biological Studies |
Samuel Pfaff |
Disease Team Planning |
Motor neuron diseases: Finding cures through basic, translational, and clinical collaboration |
$54,798 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Disease Team Planning |
Pluripotent Stem Cell–Based Therapy for Heart Disease |
$53,972 |
|
University of California, San Diego |
Lawrence Goldstein |
Early Translational III |
Identifying Drugs for Alzheimer's Disease with Human Neurons Made From Human IPS cells |
$1,857,600 |
|
California State University, Channel Islands |
Ching-Hua Wang |
Bridges |
Curriculum Development and Implementation of Stem Cell Technology and Laboratory Management Emphasis in an Established MS Biotechnology and Bioinformatics Program at (REDACTED) and Co-development of a GE Course on Stem Cel |
$3,614,553 |
|
University of California, Berkeley |
Randy Schekman |
Traning Grant I-1 |
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland |
$2,529,810 |
|
University of California, Los Angeles |
William Lowry |
Basic Biology III |
Molecular determinants of accurate differentiation from human pluripotent stem cells |
$1,354,230 |
|
University of California, Los Angeles |
Kathrin Plath |
Basic Biology III |
Discovery of mechanisms that control epigenetic states in human reprogramming and pluripotent cells |
$1,364,598 |
|
The Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Early Translational III |
Direct reprogramming towards vascular progenitors for the treatment of ischemia |
$2,340,000 |
|
California State University, Fullerton |
Nilay Patel |
Bridges |
Stem Cell Training Program - A Bridge to Stem Cell Research |
$2,710,703 |
|
University of California, Irvine |
Peter Bryant |
Traning Grant I-1 |
Stem Cell Research Training Grant |
$2,039,845 |
|
University of California, Los Angeles |
Shuo Lin |
Basic Biology III |
Etsrp/ER71 mediated stem cell differentiation into vascular lineage |
$1,382,400 |
|
University of California, San Francisco |
Harold Bernstein |
Basic Biology III |
Phenotypic Analysis of Human ES Cell-Derived Muscle Stem Cells |
$1,381,296 |
|
The Salk Institute for Biological Studies |
David Schubert |
Early Translational III |
Stem cell based small molecule therapy for Alzheimer's disease |
$1,673,757 |
|
California State University, Long Beach |
Lisa Klig |
Bridges |
CIRM Stem Cell Research Biotechnology Training Program |
$3,042,698 |
|
Scripps Research Institute |
Peter Schultz |
Traning Grant I-2 |
Training Grant I |
$1,059,300 |
|
Children's Hospital of Los Angeles |
Tracy Grikscheit |
New Faculty Physician Scientist |
The generation and expansion of tissue-engineered small intestine from human stem/ progenitor cells: a preclinical study of functional translation |
$3,408,000 |
|
Scripps Research Institute |
Kristin Baldwin |
Basic Biology III |
Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing |
$1,755,864 |
|
University of California, Davis |
John Laird |
Disease Team Therapy Planning I |
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia |
$76,861 |
|
California State University, Northridge |
Cindy Malone |
Bridges |
Bridges to Stem Cell Research |
$3,382,877 |
|
The J. David Gladstone Institutes |
Robert Mahley |
Traning Grant I-2 |
Gladstone CIRM Scholar Program |
$2,397,240 |
|
University of California, San Francisco |
Ophir Klein |
New Faculty Physician Scientist |
Stem cell therapy for inflammatory bowel disease |
$3,084,000 |
|
University of California, San Francisco |
John Murnane |
Basic Biology III |
Genomic instability during culturing of human embryonic stem cells |
$1,074,355 |
|
University of California, Davis |
Mehrdad Abedi |
Disease Team Therapy Planning I |
RUNNING TITLE: Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients |
$74,195 |
|
California State University, Sacramento |
Jane Bruner |
Bridges |
Strengthening the Pipeline of Masters-level Scientific and Laboratory Personnel in Stem Cell Research |
$2,773,463 |
|
University of California, San Francisco |
Jason Pomerantz |
New Faculty Physician Scientist |
Characterization of Human Skeletal Muscle Stem Cells for Clinical Application |
$3,084,000 |
|
University of California, Berkeley |
Michael Rape |
Basic Biology III |
Ubiquitin-dependent control of hESC self-renewal and expansion |
$1,364,091 |
|
Cedars-Sinai Medical Center |
Clive Svendsen |
iPSC Consortia Award |
The HD iPSC Consortium: Repeat Length Dependent Phenotypes for Assay Development |
$300,000 |
|
Stanford University |
Judith Shizuru |
Disease Team Therapy Planning I |
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants |
$109,676 |
|
California State University, San Bernardino |
Nicole Bournias-Vardiabasis |
Bridges |
Bridges to Stem Cell Research |
$2,607,705 |
|
University of California, Los Angeles |
Donald Kohn |
Traning Grant I-2 |
Training Grant 1 |
$2,390,826 |
|
University of California, San Francisco |
Ann Zovein |
New Faculty Physician Scientist |
Human endothelial reprogramming for hematopoietic stem cell therapy. |
$3,084,000 |
|
Beckman Research Institute of City of Hope |
Stephen Forman |
Early Translational III |
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells |
$5,217,004 |
|
California State University, San Marcos |
Bianca Mothe |
Bridges |
CIRM Bridges to the Stem Cell Research Training Grant |
$3,613,311 |
|
University of California, Santa Barbara |
Carol Pasternack |
Creativity Awards |
Research Mentorship Program-Immersing High School Students in College Research |
$223,080 |
|
University of California, Davis |
Martin Birchall |
Disease Team Therapy Planning I |
Airways for Children |
$71,248 |
|
California Institute of Technology |
Paul Patterson |
Traning Grant I-2 |
Training in Stem Cell Biology at CIT |
$2,318,580 |
|
University of California, Los Angeles |
Reza Ardehali |
New Faculty Physician Scientist |
Preclinical evaluation of human embryonic stem cell-derived cardiovascular progenitors |
$2,930,388 |
|
Stanford University |
Joseph Wu |
Early Translational III |
Heart Repair with Human Tissue Engineered Myocardium |
$4,766,231 |
|
City College Of San Francisco |
Carin Zimmerman |
Bridges |
Stem Cell Training Enhancement Program |
$2,454,307 |
|
Stanford University |
Paul Utz |
Creativity Awards |
[REDACTED] Program: Stem Cell & Developmental Biology Research Internships |
$288,750 |
|
University of California, Los Angeles |
Antoni Ribas |
Disease Team Therapy Planning I |
Genetic Re-programming of Stem Cells to Fight Cancer |
$110,000 |
|
University of California, Santa Barbara |
Dennis Clegg |
Traning Grant I-3 |
UCSB Stem Cell Biology Training Program |
$1,343,859 |
|
University of California, Irvine |
Thomas Lane |
Early Translational III |
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells |
$4,799,814 |
|
Humboldt State University |
Jacob Varkey |
Bridges |
CIRM Bridges to Stem Cell Research Certificate Program |
$3,497,510 |
|
Children's Hospital of Oakland Research Institute |
Vasanthy Narayanaswami |
Creativity Awards |
[REDACTED] Summer Stem Cell Research Internship Program for High School Students |
$115,500 |
|
Stanford University |
Albert Wong |
Disease Team Therapy Planning I |
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma |
$109,750 |
|
University of California, San Diego |
Charles King |
Basic Biology III |
Biological relevance of microRNAs in hESC differentiation to endocrine pancreas |
$1,313,649 |
|
University of California, Santa Cruz |
David Haussler |
Traning Grant I-3 |
Training Program in Systems Biology of Stem Cells |
$1,217,132 |
|
University of California, Davis |
Walter Boyd |
Early Translational III |
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair |
$4,939,140 |
|
Pasadena City College |
Pamela Eversole-Cire |
Bridges |
Bridges to Stem Cell Research |
$3,609,138 |
|
Sanford-Burnham Medical Research Institute |
Stuart Lipton |
Disease Team Therapy Planning I |
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease |
$96,448 |
|
University of California, San Diego |
Kun Zhang |
Basic Biology III |
Functional characterization of mutational load in nuclear reprogramming and differentiation |
$1,382,140 |
|
The Salk Institute for Biological Studies |
Juan Carlos Izpisua Belmonte |
Traning Grant I-3 |
Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies |
$1,496,880 |
|
University of California, Davis |
Emanual Maverakis |
New Faculty Physician Scientist |
Tunable hydrogels for therapeutic delivery of multipotent stem cells. |
$2,964,000 |
|
University of Southern California |
Toshio Miki |
Early Translational III |
Generation of hepatic cell from placental stem cell for congenital metabolic disorders |
$1,750,375 |
|
San Diego State University |
Ralph Feuer |
Bridges |
CIRM Stem Cell Internship Program |
$3,597,177 |
|
University of California, Davis |
Gerhard Bauer |
Creativity Awards |
Internship at a Cutting Edge CIRM-funded Stem Cell Research Facility |
$264,000 |
|
Geron Corporation |
Jane Lebkowski |
Disease Team Therapy Planning I |
Preclinical Development and First-In-Human Testing of [REDACTED] in Advanced Heart Failure |
$106,239 |
|
University of California, San Diego |
Farah Sheikh |
Basic Biology III |
Molecular Mechanisms Underlying Human Cardiac Cell Junction Maturation and Disease Using Human iPSC |
$1,341,955 |
|
Scripps Research Institute |
Peter Schultz |
Early Translational III |
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis |
$4,327,175 |
|
University of California, Los Angeles |
Ali Nsair |
New Faculty Physician Scientist |
Human Induced Pluripotent Stem Cell-Derived Cardiovascular Progenitor Cells for Cardiac Cell Therapy. |
$3,004,315 |
|
Children's Hospital of Orange County |
Philip Schwartz |
Early Translational III |
Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease |
$5,509,978 |
|
San Francisco State University |
Carmen Domingo |
Bridges |
Bridges to Stem Cell Research |
$3,594,705 |
|
The J. David Gladstone Institutes |
Shannon Noonan |
Creativity Awards |
[REDACTED] Summer Scholars internship program |
$30,690 |
|
University of Southern California |
Roberta Brinton |
Disease Team Therapy Planning I |
A CIRM Disease Team to Develop Allopregnanolone for Prevention and Treatment of Alzheimer's Disease |
$107,989 |
|
University of California, San Francisco |
Morton Cowan |
Early Translational III |
Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID |
$3,931,662 |
|
Stanford University |
Alan Cheng |
New Faculty Physician Scientist |
Enhancing hair cell regeneration in mouse and human inner ear |
$3,091,595 |
|
University of California, Davis |
Kyriacos Athanasiou |
Early Translational III |
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells |
$1,735,703 |
|
San Jose State University |
Tzvia Abramson |
Bridges |
Stem Cell Internships for Laboratory-based Learning (SCILL) |
$3,614,907 |
|
University of Southern California |
Roberta Brinton |
Creativity Awards |
CIRM STAR High School Summer Research and Creativity Program |
$264,000 |
|
Samumed, LLC |
John Hood |
Disease Team Therapy Planning I |
Clinical Development of an osteoinductive therapy to prevent osteoporosis-related fractures |
$99,110 |
|
University of California, San Diego |
Binhai Zheng |
Basic Biology III |
Generation and characterization of corticospinal neurons from human embryonic stem cells |
$1,355,063 |
|
University of California, San Diego |
Eric Adler |
Early Translational III |
Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease |
$1,701,575 |
|
University of California, San Diego |
Mana Parast |
New Faculty Physician Scientist |
Human pluripotent stem cell-based therapeutics for preeclampsia |
$3,013,252 |
|
Berkeley City College |
Barbara Des Rochers |
Bridges |
Specialty in Stem Cell Biology |
$2,450,257 |
|
Beckman Research Institute of City of Hope |
Paul Salvaterra |
Creativity Awards |
Creativity Award Program in Stem Cell Biology for California High School Students |
$211,200 |
|
OncoMed Pharmaceuticals, Inc. |
Timothy Hoey |
Disease Team Therapy Planning I |
[REDACTED]: A New Cancer Therapeutic to Reduce CSC Frequency |
$65,120 |
|
University of California, Los Angeles |
Yi Sun |
Basic Biology III |
Studying neurotransmission of normal and diseased human ES cell-derived neurons in vivo |
$1,382,400 |
|
University of California, San Francisco |
Holger Willenbring |
Early Translational III |
Generation of safe and therapeutically effective human induced hepatocyte-like cells |
$1,544,170 |
|
Stanford University |
Michelle Monje |
New Faculty Physician Scientist |
White matter neuroregeneration after chemotherapy: stem cell therapy for “chemobrain” |
$2,800,536 |
|
Scripps Research Institute |
James Williamson |
Creativity Awards |
Stem Cell Summer Academy: Creating the Next Generation of Scientists |
$206,250 |
|
University of California, Davis |
Nancy Lane |
Disease Team Therapy Planning I |
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis |
$110,000 |
|
The J. David Gladstone Institutes |
Deepak Srivastava |
Basic Biology III |
Mechanisms of Direct Cardiac Reprogramming |
$1,708,560 |
|
University of California, Berkeley |
Zhigang He |
Research Leadership 7 |
Developing a regeneration-based functional restoration treatment for spinal cord injury |
$5,609,890 |